An international panel of experts has recently proposed criteria for defining a new clinical
entity called CAPAdcoronavirus disease 2019 (COVID-19)-associated pulmonary …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

Invasive pulmonary aspergillosis (IPA) in intensive care unit patients is a major concern.
Influenza-associated acute respiratory distress syndrome (ARDS) and severe COVID-19 …

We performed an observational study to investigate intensive care unit incidence, risk
factors, and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA) …

Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) occurs in critically ill patients with COVID-19. Risks and outcomes …

Rationale: Invasive pulmonary aspergillosis has emerged as a frequent coinfection in
severe coronavirus disease (COVID-19), similarly to influenza, yet the clinical invasiveness …

Background An increasing number of reports have described the COVID‐19–associated
pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …